Investors
Issue Archive
| Document | File | Date |
|---|---|---|
| Rights Issue 2023 | ||
| EU-tillväxtprospekt | ||
| Emissionsfolder | ||
| Anmälningssedel för teckning av aktier med stöd av teckningsrätter | ||
| Anmälningssedel för teckning av aktier utan stöd av teckningsrätter | ||
| The board of directors’ resolution on rights issue | ||
| The board of directors’ report | ||
| Auditor’s statement | ||
| Directed Issue 2023 | ||
| The board of directors’ resolution on directed set-off issue | ||
| The board of directors’ report | ||
| Auditor’s statement | ||
| TO1 2022 | ||
| Informationsblad TO1 | May 19 2022 | |
| Anmälningssedel | May 19 2022 | |
| Terms for warrants of series TO1 | June 22 2021 | |
| IPO 2021 | ||
| Tilläggsdokument avseende notering av Modus Therapeutics Holding AB (Swedish Only) | July 20 2021 | |
| The offer in summary | June 22 2021 | |
| Subscribe units in Modus | June 30 2021 | |
| Prospectus-Modus | June 29 2021 | |
| Prospectus-Summary-Finnish | June 29 2021 | |
| Prospectus-Summary-Norwegian | June 29 2021 | |
| Teaser-English | June 29 2021 | |
| Teaser-Danish | June 29 2021 | |
| Terms for warrants of series TO1 | June 22 2021 | |
| Basic information document | June 29 2021 | |